Biblio
Export 1991 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is B [Clear All Filters]
“Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S87-S99, 2019.
, “Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 67, no. 2, pp. 639-651, 2019.
, “Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.”, J Alzheimers Dis, vol. 72, no. 1, pp. 301-318, 2019.
, “Intraneuronal Tau Misfolding Induced by Extracellular Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 71, no. 4, pp. 1125-1138, 2019.
, “Intraneuronal Tau Misfolding Induced by Extracellular Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 71, no. 4, pp. 1125-1138, 2019.
, “Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model.”, J Alzheimers Dis, vol. 67, no. 2, pp. 503-513, 2019.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
, “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
, “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
, “Neurodegenerative Disease-Related Proteins within the Epidermal Layer of the Human Skin.”, J Alzheimers Dis, vol. 69, no. 2, pp. 463-478, 2019.
, “Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 1, pp. 291-302, 2019.
, “The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 4, pp. 983-993, 2019.
, “Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 3, pp. 969-981, 2019.
, “Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 3, pp. 969-981, 2019.
, “Present Algorithms and Future Treatments for Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 4, pp. 1157-1171, 2019.
, “The Prevalence and Subtypes of Young Onset Dementia in Central Norway: A Population-Based Study.”, J Alzheimers Dis, vol. 69, no. 2, pp. 479-487, 2019.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
, “Self and Informant Memory Reports in FINGER: Associations with Two-Year Cognitive Change.”, J Alzheimers Dis, vol. 71, no. 3, pp. 785-795, 2019.
, “Sirtuin 3 Mediates Tau Deacetylation.”, J Alzheimers Dis, vol. 69, no. 2, pp. 355-362, 2019.
, “Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling.”, J Alzheimers Dis, vol. 67, no. 3, pp. 1089-1106, 2019.
, “Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S119-S144, 2019.
, “Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 2, pp. 543-557, 2019.
, “Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 3, pp. 893-910, 2019.
,